GB1517540A - Preparation for the treatment of infectious diseases method for the manufacture thereof and its use - Google Patents

Preparation for the treatment of infectious diseases method for the manufacture thereof and its use

Info

Publication number
GB1517540A
GB1517540A GB32217/75A GB3221775A GB1517540A GB 1517540 A GB1517540 A GB 1517540A GB 32217/75 A GB32217/75 A GB 32217/75A GB 3221775 A GB3221775 A GB 3221775A GB 1517540 A GB1517540 A GB 1517540A
Authority
GB
United Kingdom
Prior art keywords
preparation
manufacture
treatment
infectious diseases
diseases method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32217/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742437166 external-priority patent/DE2437166C3/de
Application filed by Individual filed Critical Individual
Publication of GB1517540A publication Critical patent/GB1517540A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
GB32217/75A 1974-08-01 1975-08-01 Preparation for the treatment of infectious diseases method for the manufacture thereof and its use Expired GB1517540A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742437166 DE2437166C3 (de) 1974-08-01 Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten

Publications (1)

Publication Number Publication Date
GB1517540A true GB1517540A (en) 1978-07-12

Family

ID=5922207

Family Applications (1)

Application Number Title Priority Date Filing Date
GB32217/75A Expired GB1517540A (en) 1974-08-01 1975-08-01 Preparation for the treatment of infectious diseases method for the manufacture thereof and its use

Country Status (13)

Country Link
US (1) US4053582A (cg-RX-API-DMAC7.html)
JP (1) JPS5141420A (cg-RX-API-DMAC7.html)
AT (1) AT343797B (cg-RX-API-DMAC7.html)
BE (1) BE831691A (cg-RX-API-DMAC7.html)
CA (1) CA1057195A (cg-RX-API-DMAC7.html)
CH (1) CH614627A5 (cg-RX-API-DMAC7.html)
DK (1) DK141835C (cg-RX-API-DMAC7.html)
ES (1) ES439966A1 (cg-RX-API-DMAC7.html)
FR (1) FR2280390A1 (cg-RX-API-DMAC7.html)
GB (1) GB1517540A (cg-RX-API-DMAC7.html)
NL (1) NL7509136A (cg-RX-API-DMAC7.html)
SE (1) SE7508565L (cg-RX-API-DMAC7.html)
ZA (1) ZA754725B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037441A1 (en) * 1980-03-10 1981-10-14 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
EP0077063B1 (en) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
EP0080032A3 (en) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions
US4497795A (en) * 1982-12-13 1985-02-05 The Texas A&M University System Method of regulating appetite and efficiency of food utilization employing interferon
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US4758426A (en) * 1987-06-11 1988-07-19 Ramsdell Bruce V Therapeutic toilet solution and method of dispersion
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
US5215745A (en) * 1988-04-27 1993-06-01 United Cancer Research Institute Method for treating viral diseases with attenuated virus
ES2310580T3 (es) 1993-04-30 2009-01-16 Wellstat Biologics Corporation Composiciones purificadas del virus de la enfermedad de newcastle.
FR2707458B1 (fr) * 1993-07-12 1995-10-06 Sagal Ingrédients alimentaires obtenus par fermentation avec S. Boulardii et aliments les contenant.
US6140107A (en) * 1996-09-25 2000-10-31 Viva America Marketing, Inc. Organometallic-metabolizing yeast
GB9711957D0 (en) * 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
US20030138454A1 (en) * 1997-06-09 2003-07-24 Oxxon Pharmaccines, Ltd. Vaccination method
GB0118532D0 (en) * 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
GB2396814B (en) * 2001-11-30 2006-07-19 Isis Innovation Fowlpox vector
US20050175627A1 (en) * 2003-09-24 2005-08-11 Oxxon Therapeutics Ltd. HIV pharmaccines
DE10349115A1 (de) * 2003-10-22 2005-06-16 Biosyn Arzneimittel Gmbh Kombinationspräparat zur Behandlung der Sepsis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429965A (en) * 1966-08-01 1969-02-25 Sterling Drug Inc Avian pox virus vaccine and process of preparing same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037441A1 (en) * 1980-03-10 1981-10-14 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein

Also Published As

Publication number Publication date
US4053582A (en) 1977-10-11
DE2437166B2 (de) 1977-01-27
CH614627A5 (cg-RX-API-DMAC7.html) 1979-12-14
SE7508565L (sv) 1976-02-02
DE2437166A1 (de) 1976-02-19
FR2280390A1 (fr) 1976-02-27
CA1057195A (en) 1979-06-26
JPS5141420A (cg-RX-API-DMAC7.html) 1976-04-07
DK141835B (da) 1980-06-30
ATA598975A (de) 1977-10-15
DK141835C (da) 1980-11-10
BE831691A (fr) 1975-11-17
NL7509136A (nl) 1976-02-03
AT343797B (de) 1978-06-12
ES439966A1 (es) 1977-03-01
FR2280390B1 (cg-RX-API-DMAC7.html) 1980-04-11
DK347775A (da) 1976-02-02
ZA754725B (en) 1976-06-30

Similar Documents

Publication Publication Date Title
SE7508565L (sv) Preparat for behandling av infektionssjukdomar forfarande for dess framstellning samt anvendning av dylikt preparat.
BE827127A (fr) Nouveaux derives d'acide oxy-16 prostanoique, leur procede de preparation et leur utilisation therapeutique
ZA7469B (en) Compositions and treatment of proliferative skin diseases with-c-amp analogs
JPS52114018A (en) Purification and isolation of hepatisis virus for producing vaccine
DE3174807D1 (en) Pharmaceutical composition
BE837078A (fr) Procede de preparation de fluorures d'acides perfluoralcoxypropioniques
JPS55154919A (en) Preparation of interferon
ES439804A1 (es) Un procedimiento para la preparacion de aminas.
CH611797A5 (en) Process for the preparation of pilocarpine pamoate
DE3780814D1 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
BE828259A (fr) Procede de preparation de derives de l'adenine rendus fonctionnels et produits obtenus par ce procede
FR2283159A1 (fr) Procede de preparation de produits d'hydrolyse de copolymeres ethylene-acetate de vinyle
EG11811A (en) Process for preparing of anthelmintically active 2-carbalkoxyamino benzimidazolyl-5(6)sulfonic acid phenyl esters and their use for combatting diseases coused by parasites in human and animals
GB1466633A (en) Method for immunizing nursing piglets against transmissible gastroenteritis -tge- virus
PT70556A (en) Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines
EP0516845A4 (en) NEW MEGAKARYOCYTIC COLONY-STIMULATING FACTOR AND METHOD FOR THE PRODUCTION THEREOF.
GB1490290A (en) Preparation of penicillanic acid derivatives
GB1462545A (en) Feline rhinotracheitis vaccine and production thereof
DE2961328D1 (en) Preparation of oxy-halogenated acids and their salts by electrolysis
GB1358321A (en) Method od tissue cell culture
AT336190B (de) Verfahren zur herstellung von mikropellets zur behandlung von erkrankungen des mund- und rachenraumes
GB1503095A (en) Process for stimulating wool and hair growth
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
ZA74404B (en) 4,8-dimethoxy-furo(3',2'-f)benzoxazol-2-yl acethydroxamic acid,its process of preparation and its therapeutic application
FR2282416A1 (fr) Procede de preparation de produits d'autocondensation

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee